For yet another consecutive year, ProGnosis Biotech was a proud exhibitor in MEDICA 2025, one of the world’s leading medical tech and diagnostics fair, held from November 17-20 in Düsseldorf, Germany. The company welcomed industry professionals presenting its latest advancements in Diagnostic and Hygiene Monitoring Technologies.

At the booth, ProGnosis Biotech showcased its Hygiene Monitoring Solutions. Along with the real-time surface and water ATP tests the new Protein-Flow swab test was presented as the ideal solution for protein residue detection.A key highlight was the live demonstration of ATP-FemtoFLOW, the company’s newest generation ATP test. With a limit of detection (LOD) four times lower than conventional ATP assays, it enables highly accurate ATP recovery from surfaces in ICUs, cleanrooms, biosafety laboratories and other critical environments. These new innovative products aim to enhance the efficiency of hygiene verification across laboratory and industrial environments.

The team also presented ProGnosis Biotech’s Contract Manufacturing Services, emphasizing flexible assay development and production capabilities backed by strong R&D expertise and certified manufacturing facilities.

In addition, visitors explored the company’s growing Clinical Diagnostics portfolio, including tests for respiratory viruses capable of detecting COVID-19, RSV, Adenovirus and Influenza A & B, from the same sample.

MEDICA 2025 offered a valuable opportunity for ProGnosis Biotech to connect with healthcare professionals, exchange insights and discuss the latest trends shaping the industry. The strong engagement throughout the exhibition reaffirmed the company’s commitment to delivering practical, reliable and sustainable solutions that meet real-world diagnostic and hygiene-monitoring needs.